How to use intravesical chemo post-TUR to treat TCC


The predictable recurrence of superficial transitional cell carcinoma of the urinary bladder is responsible for the frequent utilization of intravesical therapy. In the past 2 years, we have changed our intravesical treatment strategy at Ohio State University in an effort to enhance efficacy and reduce patient inconvenience.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.